Enterprise Value:
$3.60B+$27.98M(+0.78%)Summary
- As of today, RARE enterprise value is $3.60 billion, with a rise of +$27.98 million (+0.78%) during the most recent trading session on November 18, 2025.
- Over the past year, RARE enterprise value has dropped by -$732.15 million (-16.92%).
- RARE enterprise value is now -68.31% below its all-time high of $11.34 billion.
Performance
RARE Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
RARE Enterprise Value Trends
| PeriodPeriod | Enterprise ValueEnterprise Value | Market CapMarket Cap | PricePrice |
|---|---|---|---|
| 1D1 Day | +0.8% | +0.9% | +0.9% |
| 1M1 Month | +33.2% | +0.6% | +0.6% |
| 3M3 Months | +10.7% | +10.7% | +10.5% |
| 6M6 Months | -4.2% | -5.9% | -7.8% |
| YTDYTD | -14.1% | -18.6% | -22.0% |
| 1Y1 Year | -16.9% | -21.6% | -25.0% |
| 5Y5 Years | -49.7% | -58.0% | -71.2% |
RARE Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | $3.83B | -6.2% | $2.70B | +33.2% |
| 3M | 3-Month | $3.83B | -6.2% | $2.42B | +48.5% |
| 6M | 6-Month | $4.38B | -17.9% | $2.42B | +48.5% |
| 1Y | 1-Year | $4.84B | -25.8% | $2.42B | +48.5% |
| 3Y | 3-Year | $5.63B | -36.1% | $2.42B | +48.8% |
| 5Y | 5-Year | $11.34B | -68.3% | $2.37B | +51.6% |
| All-Time | All-Time | $11.34B | -68.3% | $837M | +329.4% |
RARE Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $3.60B(-14.1%) |
| 2024 | $4.18B(-2.5%) |
| 2023 | $4.29B(+25.8%) |
| 2022 | $3.41B(-37.8%) |
| 2021 | $5.48B(-34.9%) |
| 2020 | $8.42B(+307.4%) |
| Date | Value |
|---|---|
| 2019 | $2.07B(+18.0%) |
| 2018 | $1.75B(-3.4%) |
| 2017 | $1.81B(-28.0%) |
| 2016 | $2.52B(-35.8%) |
| 2015 | $3.92B(+223.3%) |
| 2014 | $1.21B |
FAQ
- What is Ultragenyx Pharmaceutical Inc. enterprise value?
- What is the all-time high enterprise value for Ultragenyx Pharmaceutical Inc.?
- What is RARE enterprise value year-to-date change?
- What is Ultragenyx Pharmaceutical Inc. enterprise value year-on-year change?
What is Ultragenyx Pharmaceutical Inc. enterprise value?
The current enterprise value of RARE is $3.60B
What is the all-time high enterprise value for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high enterprise value is $11.34B
What is RARE enterprise value year-to-date change?
Ultragenyx Pharmaceutical Inc. enterprise value has changed by -$588.59M (-14.07%) since the beginning of the year
What is Ultragenyx Pharmaceutical Inc. enterprise value year-on-year change?
Over the past year, RARE enterprise value has changed by -$732.15M (-16.92%)